Optimum diagnostic pathway and pathologic confirmation rate of early stage lung cancer: Results from the VIOLET randomised controlled trial.
Harris RA, Stokes EA, Batchelor TJP, Internullo E, West D, Jordan S, Nicholson AG, Paul I, Jacobs C, Shackcloth M, Feeney S, Anikin V, McGonigle N, Steyn R, Kalkat M, Stavroulias D, Havinden Williams M, Qadri S, Dobbs K, Zamvar V, Macdonald L, Kaur S, Rogers CA, Lim E; VIOLET trialists.
Harris RA, et al. Among authors: paul i.
Lung Cancer. 2025 Jan;199:108070. doi: 10.1016/j.lungcan.2024.108070. Epub 2024 Dec 26.
Lung Cancer. 2025.
PMID: 39761624
Free article.
Clinical Trial.